Effect of Dexmedetomidine on Pacemaker Function Following Cardiac Surgery
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Amplitude
研究概览
简要总结
This is a prospective study looking at the effects of dexmedetomidine on pacemaker function in patients who have surgery for congenital heart disease utilizing cardiopulmonary bypass (CBP). For the purpose of the study, no change in intraoperative care will be dictated. The use of dexmedetomidine will be left up to the discretion of the treating physicians. The study will involve only the collection of data regarding the amplitude required to capture and specific demographics and intraoperative features including cross clamp time, time on CPB, and vasoactive agents that were and are being administered. In addition to these data, it will be noted whether dexmedetomdine was used or not and whether it is being administered on arrival to the CTICU.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 6 Months 至 —(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with temporary surface pacemaker leads following surgery for congenital heart disease.
排除标准
- •Patients with single ventricle anatomy
- •Patients receiving epinephrine
- •Infants less than 6 months of age
研究组 & 干预措施
Dexmedetomidine
Patients that received dexmedetomidine during open heart surgery.
干预措施: Dexmedetomidine (Drug)
结局指标
主要结局
Amplitude
时间窗: Baseline
The impulse required to elicit atrial or ventricle capture (contraction) of the surface electrode of a temporary postoperative pacemaker.
次要结局
未报告次要终点
研究者
Joseph D. Tobias
Chief, Department of Anesthesiology & Pain Medicine
Nationwide Children's Hospital
